Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
SK hynix Shares Dip Amid Tech Sell-Off, Dividend Dates Set
SK hynix closed at 839,000 won, down 0.36%, as the KOSPI fell 1.4% to end a six-week rally. The company announced a 1,875 won per share dividend with key dates in late February.
Roche's MS Drug Trial Results Spark Investor Scrutiny Ahead of Key Presentation
Roche's experimental multiple sclerosis drug fenebrutinib met its primary endpoint in a late-stage study but showed higher liver enzyme elevations and fatalities versus Ocrevus. Investors await Monday's detailed data webcast.
Roche's MS Drug Trial Results Set Stage for Monday Investor Scrutiny
Roche's fenebrutinib met its primary endpoint in a late-stage PPMS trial, showing non-inferiority to Ocrevus but with higher liver enzyme elevations and fatal cases. Shares closed at 356.40 Swiss francs, down 0.6%.
Bank of America Rises with Broader Rally, Eyes on Key Economic Data
Bank of America shares advanced 2.9% to $56.53 on Friday, joining a market surge that pushed the Dow above 50,000. Investors now await delayed U.S. jobs and inflation figures, which could influence interest rate expectations.
Mastercard Shares Dip as Investors Eye Executive Compensation and Upcoming Economic Data
Mastercard shares closed lower Friday at $548.74, underperforming peers Visa and American Express. The company disclosed increased executive pay and a new dividend, while markets await key U.S. jobs and inflation reports.
Mastercard Slips as Executive Pay Rises, Markets Eye Jobs Data
Mastercard shares declined 0.6% to $548.74 Friday, underperforming peers Visa and American Express. The company increased compensation for top executives and declared a quarterly dividend of $0.87 per share.
Visa Eyes Key Economic Data After Mixed Week, Launches Small-Business Initiative
Visa shares edged higher Friday, closing at $331.58, as traders await a deluge of delayed U.S. economic reports next week that could sway consumer spending and rate expectations.
JNJ Nears 52-Week Peak Amid Legal Win and Promising Heart Device Data
Johnson & Johnson shares approach a 52-week high after a New Jersey court disqualified a plaintiffs' firm from talc cases and the company released positive pilot data for its experimental atrial fibrillation platform.
Johnson & Johnson Stock Nears 52-Week High Amid Legal and Medical Device Updates
Johnson & Johnson shares approached a 52-week high as a New Jersey court disqualified a plaintiffs' firm from talc cases and the company reported positive pilot data for its atrial fibrillation platform.
